News

ReiThera will be involved in setting up both Upstream Process (USP) and Downstream Process (DSP) conditions for GMP-compatible manufacturing of an AAV candidate specifically retargeted to muscle [...]

        More than 1000 Sabin Vaccine Institute Ebola Sudan vaccine doses have reached Uganda to support WHO’s outbreak response in the country December 8, 2022 Sabin Vaccine Institute is the [...]

New 1,500 sq.m. facility granted operational authorisation from AIFA, the Italian Medicines Agency, to enable production scales of up to 3,000 liters; New facility will allow ReiThera to [...]

From October 11 to 14, #ReiThera will attend the 𝟮𝟵𝘁𝗵 𝗘𝘂𝗿𝗼𝗽𝗲𝗮𝗻 𝗦𝗼𝗰𝗶𝗲𝘁𝘆 𝗳𝗼𝗿 𝗚𝗲𝗻𝗲 & 𝗖𝗲𝗹𝗹 𝗧𝗵𝗲𝗿𝗮𝗽𝘆 (#ESGCT) 𝗔𝗻𝗻𝘂𝗮𝗹 𝗖𝗼𝗻𝗴𝗿𝗲𝘀𝘀 at the Edinburgh International Conference Centre, which brings together [...]

·      GRAd-COV2 vaccine based on a recently developed group C gorilla adenoviral vector ·      Phase 2 trial confirms favorable safety profile for single and double dose regimens ·      [...]

Sleeping Beauty (SB) is the first DNA transposon employed for efficient transposition in vertebrate cells, opening new applications for genetic engineering and gene therapies. A transposonbased [...]

We are excited to invite you to visit #ReiThera at the #BIOInternationalConvention in San Diego, the largest global event for the biotech & life sciences industry that attracts thousands of [...]

ReiThera and Exothera Collaborate to Develop Large-scale, Low Cost per Dose Manufacturing Process to Deliver Novel Vaccines to Low- and Middle- Income Countries Collaboration awarded €3 million [...]

  With the public notice “Contributions for the support of digitalization processes of companies in the Lazio region – Digital Diagnostic Voucher”, the Lazio Region intends [...]

Originally published on npj Vaccines volume 6, Article number: 131 (2021). Chiara Agrati, Stefania Capone, Concetta Castilletti, Eleonora Cimini, Giulia Matusali, Silvia Meschi, Eleonora [...]